Hiroyasu Okazaki Selected Research

Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)

1/2020	Blockade of Pan-Fibroblast Growth Factor Receptors Mediates Bidirectional Effects in Lung Fibrosis.
1/2017	Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyasu Okazaki Research Topics

Disease

5	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 10/2013
3	Idiopathic Pulmonary Fibrosis 01/2020 - 01/2017
2	Fibrosis (Cirrhosis) 01/2020 - 01/2017
1	Takotsubo Cardiomyopathy 07/2022
1	Heart Arrest (Cardiac Arrest) 07/2022
1	Lung Diseases (Lung Disease) 07/2022

Drug/Important Bio-Agent (IBA)

5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 10/2013
3	nintedanibIBA 01/2020 - 01/2017
2	indium-bleomycinIBA 01/2020 - 10/2013
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2020 - 01/2017
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 01/2017
1	AutoantibodiesIBA 07/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	Growth Factor ReceptorsIBA 01/2020
1	infigratinibIBA 01/2020
1	ICG 001IBA 01/2019
1	CateninsIBA 01/2019
1	Blocking AntibodiesIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Platelet-Derived Growth FactorIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2013
1	TAE226IBA 10/2013

Therapy/Procedure

1	Therapeutics 01/2019